Abstract
Various strains of Lactobacillus and Leuconostoc species were evaluated to select the most promising strain to carry out transforming major ginsenosides into minor ginsenosides. Among the experimental lactic acid bacteria (LAB), Leuconostoc mesenteroides KFRI 690, Leuconostoc paramesenteroides KFRI 159, and Lactobacillus delbrueckii KCCM 35486 produced compound K from major ginsenosides precursors (Rb1, Rc, Rd, and F2). KFRI 690 showed the best transforming activity among them. Furthermore, these LABs could biotransform ginsenosides without disrupting the cell to release enzyme activity. The conversion ratio of Rb1 to compound K using KFRI 690 has been enhanced up to 97.8% by adding 2% sucrose into the culture medium. This is the first report on the production of compound K using whole cells of Leu. mesenteroides, Leu. paramesenteroides, and Lb. delbrueckii, which are food grade lactic acid bacteria.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Akao T, Kida H, Kanaoka M, Hattori M, Kobashi, K. Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng. J. Pharm. Pharmacol. 50: 1155–1160 (1998)
Sun J, Wang G, Haitang X, Hao L, Guoyu P, Tucker I. Simultaneous rapid quantification of ginsenoside Rg1 and its secondary glycoside Rh1 and aglycone protopanaxatriol in rat plasma by liquid chromatography-mass spectrometry after solid-phase extraction. J. Pharm. Biomed. Anal. 38: 126–132 (2005)
Gillis CN. Panax ginseng pharmacology. Biochem. Pharmacol. 54: 1–8 (1997)
Attele AS, Wu JA, Yuan CS. Multiple constituents and multiple actions. Biochem. Pharmacol. 58: 1685–1693 (1999)
Buettner C, Yeh GY, Phillips RS, Mittleman MA, Kaptchuk TJ. Systematic review of the effects of ginseng on cardiovascular risk factors. Ann. Pharmacother. 40: 83–95 (2006)
Hofseth LJ, Wargovich MJ. Inflammation, cancer, and targets of ginseng. J. Nutr. 137: 183S (2007)
Kim MW, Ko SR, Choi KJ, Kim SC. Distribution of saponin in various sections of Panax ginseng root and changes of its contents according to root age. J. Ginseng Sci. 11: 10–16 (1987)
Park CS, Yoo MH, Noh KH, Oh DK. Biotransformation of ginsenosides by hydrolyzing the sugar moieties of ginsenosides using microbial glycosidases. Appl. Microbiol. Biot. 87: 9–19 (2010)
Karikura M, Miyase T, Tanizawa H, Taniyama T, Takino Y. Studies on absorption, distribution, excretion, and metabolism of ginseng saponins. VII. Comparison of the decomposition modes of ginsenoside-Rb1 and-Rb2 in the digestive tract of rats. Chem. Pharm. Bull. 39: 2357–2361 (1991)
Tawab MA, Bahr U, Karas M, Wurglics M, Schubert-Zsilavecz M. Degradation of ginsenosides in humans after oral administration. Drug Metab. Dispos. 31: 1065–1071 (2003)
Hasegawa H, Uchiyama M. Antimetastatic efficacy of orally administered ginsenoside Rb1 in dependence on intestinal bacterial hydrolyzing potential and significance of treatment with an active bacterial metabolite. Planta Med. 64: 696–700 (1998)
Chi H, Ji GE. Transformation of ginsenosides Rb1 and Re from Panax ginseng by food microorganisms. Biotechnol. Lett. 27: 765–771 (2005)
Kim MK, Lee JW, Lee KY, Yang DC. Microbial conversion of major ginsenoside Rb1 to pharmaceutically active minor ginsenoside Rd. J. Microbiol. 43: 456–462 (2005)
Keum YS, Park KK, Lee JM, Chun KS, Park JH, Lee SK, Kwon H, Surh YJ. Antioxidant and anti-tumor promoting activities of the methanol extract of heat-processed ginseng. Cancer Lett. 150: 41–48 (2000)
Cheng LQ, Na JR, Bang MH, Kim MK, Yang DC. Conversion of major ginsenoside Rb1 to 20 (S)-ginsenoside Rg3 by Microbacterium sp. GS514. Phytochemistry 69: 218–224 (2008)
Zhao X, Wang J, Li J, Fu L, Gao J, Du X, Bi H, Zhou Y, Tai G. Highly selective biotransformation of ginsenoside Rb 1 to Rd by the phytopathogenic fungus Cladosporium fulvum (syn. Fulvia fulva). J. Ind. Microbiol. Biot. 36: 721–726 (2009)
Quan LH, Cheng LQ, Kim HB, Kim JH, Son NR, Kim SY, Jin HO, Yang DC. Bioconversion of ginsenoside Rd into compound K by Lactobacillus pentosus DC101 isolated from kimchi. J. Ginseng Res. 34: 288–295 (2010)
Chi H, Kim DH, Ji GE. Transformation of ginsenosides Rb2 and Rc from Panax ginseng by food microorganisms. Biol. Pharm. Bull. 28: 2102–2105 (2005)
Chi H, Lee BH, You HJ, Park MS, Ji GE. Differential transformation of ginsenosides from Panax ginseng by lactic acid bacteria. J. Microbiol. Biotechn. 16: 1629–1633 (2006)
Yan Q, Zhou W, Li X, Feng M, Zhou P. Purification method improvement and characterization of a novel ginsenoside-hydrolyzing β-glucosidase from Paecilomyces Bainier sp. 229. Biosci. Biotech. Bioch. 72: 352–359 (2008)
Noh KH, Oh DK. Production of the rare ginsenosides compound K, compound Y, and compound Mc by a thermostable β-glycosidase from Sulfolobus acidocaldarius. Biol. Pharm. Bull. 32: 1830–1835 (2009)
Quan LH, Cheng LQ, Na JR, Kim HB, Park MJ, Kim SH, Kim MK, Yang DC. Transformation of ginsenoside Rd to ginsenoside F2 by enzymes of Leuconostoc fallax LH3. Korean J. Med. Crop Sci. 16: 155–160 (2008)
Gueguen Y, Chemardin P, Labrot P, Arnaud A, Galzy P. Purification and characterization of an intracellular β-glucosidase from a new strain of Leuconostoc mesenteroides isolated from cassava. J. Appl. Microbiol. 82: 469–476 (1997)
Coulon S, Chemardin P, Gueguen Y, Arnaud A, Galzy P. Purification and characterization of an intracellular β-glucosidase from Lactobacillus casei ATCC 393. Appl. Biochem. Biotechnol. 74: 105–114 (1998)
Quan LH, Piao JY, Min JW, Yang DU, Lee HN, Yang DC. Bioconversion of ginsenoside Rb1 into compound K by Leuconostoc citreum LH1 isolated from kimchi. Braz. J. Microbiol. 42: 1227–1237 (2011)
Yang DC. Biotransformation of ginsenoside Rb1 to prosapogenins, gypenoside XVII, ginsenoside Rd, ginsenoside F2, and compound K by Leuconostoc mesenteroides DC102. J. Ginseng Res. 35: 344–351 (2011)
Lee SJ, Ko WG, Kim JH, Sung JH, Moon CK, Lee BH. Induction of apoptosis by a novel intestinal metabolite of ginseng saponin via cytochrome c-mediated activation of caspase-3 protease. Biochem. Pharmacol. 60: 677–685 (2000)
Oh SH, Yin HQ, Lee BH. Role of the Fas/Fas ligand death receptor pathway in ginseng saponin metabolite-induced apoptosis in HepG2 cells. Arch. Pharm. Res. 27: 402–406 (2004)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Park, S.J., Youn, S.Y., Ji, G.E. et al. Whole cell biotransformation of major ginsenosides using Leuconostocs and Lactobacilli . Food Sci Biotechnol 21, 839–844 (2012). https://doi.org/10.1007/s10068-012-0108-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10068-012-0108-z